This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Phosphorylation of the regulatory light chain of myosin in striated muscle: methodological perspectives
European Biophysics Journal Open Access 15 April 2016
-
Design of a colicin E7 based chimeric zinc-finger nuclease
Journal of Computer-Aided Molecular Design Open Access 22 June 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. published online, doi:10.1038/nbt.2884 (31 March 2014).
Aiuti, A. et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341, 1233151 (2013).
Tebas, P. et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N. Engl. J. Med. 370, 901–910 (2014).
Nathwani, A.C. et al. Adenovirus-associated virus vector–mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357–2365 (2011).
Li, H. et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217–221 (2011).
Wu, Y. et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 13, 659–662 (2013).
Schwank, G. et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13, 653–658 (2013).
Gaj, T., Gersbach, C.A. & Barbas, C.F. III. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397–405 (2013).
Mali, P., Esvelt, K.M. & Church, G.M. Cas9 as a versatile tool for engineering biology. Nat. Methods 10, 957–963 (2013).
Geall, A.J. et al. Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl. Acad. Sci. USA 109, 14604–14609 (2012).
Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 29, 816–823 (2011).
Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270–276 (1997).
Ethics declarations
Competing interests
K.H. has pending patents on ZFN-mediated genome editing in the liver and a patent on the use of AAV vectors to deliver clotting factor genes to the liver. P.D.G. is an employee of Sangamo Biosciences. C.G. is a consultant in the area of genome editing for several companies and an inventor on patent applications related to genome editing for the correction of genetic diseases.
Rights and permissions
About this article
Cite this article
CRISPR technology for gene therapy. Nat Med 20, 476–477 (2014). https://doi.org/10.1038/nm.3566
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3566
This article is cited by
-
In vivo gene therapy potentials of CRISPR-Cas9
Gene Therapy (2016)
-
Phosphorylation of the regulatory light chain of myosin in striated muscle: methodological perspectives
European Biophysics Journal (2016)
-
Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells
Cell Research (2015)
-
Design of a colicin E7 based chimeric zinc-finger nuclease
Journal of Computer-Aided Molecular Design (2014)